4-碘吡啶-2-甲酸甲酯 | 380381-28-2

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 4-碘吡啶-2-甲酸甲酯
• 中文别名: 4-碘吡啶甲酸甲酯；4-碘-2-吡啶甲酸甲酯
• 英文名称: 4-iodopicolinic acid methyl ester
• 英文别名: methyl 4-iodopicolinate；Methyl 4-iodopyridine-2-carboxylate
• CAS: 380381-28-2
• 化学式: C₇H₆INO₂
• 分子量: 263.035
• InChiKey: HSNLSLNACLYWKJ-UHFFFAOYSA-N

物化性质

• 熔点：
  70-73
• 沸点：
  327.6±27.0 °C(Predicted)
• 密度：
  1.844±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  39.2
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2933399090
• 储存条件：
  保持冷静

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 4-iodopicolinate
Synonyms: 4-Iodo-2-pyridinecarboxylic acid methyl ester

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 4-iodopicolinate
CAS number: 380381-28-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H6INO2
Molecular weight: 263.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen Iodide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-碘吡啶-2-甲酸甲酯 在 乙醇 、 一水合肼 作用下， 生成 4-iodo-pyridine-2-carboxylic acid hydrazide
  参考文献：
  名称：

  Graf, Chemische Berichte, 1931, vol. 64, p. 21,26

  摘要：

  DOI：
• 作为产物：
  描述：

  4-氯吡啶-2-甲酸甲酯 在 硫酸 、 氢碘酸 、 次磷酸 作用下， 反应 49.0h， 生成 4-碘吡啶-2-甲酸甲酯
  参考文献：
  名称：

  Allosteric modulators of 5-hydroxytryptamine 2C receptor (5-HT2CR)

  摘要：

  该披露涉及被确定为5-HT 2CR的别构调节剂的化合物，以及使用这些化合物的药物组合物和方法。某些实施例还包括鉴定方法和合成这些化合物的方法。优化和开发结合非主要配体结合位点的别构5-HT 2CR调节剂，可生成新颖、高选择性和高效的5-HT2CR配体。这些分子可以用作神经系统的小分子探针，也可以作为多种疾病的有效治疗药物。

  公开号：

  US09533973B2
• 作为试剂：
  描述：

  4-碘吡啶-2-羧酸 、 硫酸 、 甲醇 在 4-碘吡啶-2-甲酸甲酯 作用下， 反应 48.0h， 以to yield the desired product 4-iodopicolinic acid methyl ester 11b (4.4 g, 90%) as a yellow oil的产率得到4-碘吡啶-2-甲酸甲酯
  参考文献：
  名称：

  Lincomycin derivatives possessing antibacterial activity

  摘要：

  新型林可霉素衍生物被披露。这些林可霉素衍生物表现出抗菌活性。该发明的化合物可能对包括革兰氏阳性菌在内的细菌表现出强效活性，并可作为有用的抗微生物剂。还披露了合成和使用这些化合物的方法。

  公开号：

  US07361743B2

文献信息

• Novel oxazolidinone derivatives and a process for the preparation thereof
  申请人：——

  公开号：US20030166620A1

  公开（公告）日：2003-09-04

  The present invention relates to novel oxazolidinone derivatives, their pharmaceutically acceptable salts and a process for the preparation thereof. More particularly, the present invention relates to oxazolidinone derivatives having pyridine or pyrimidine moeity substituted by heterocycle and heteroaromaticcycle at 4-position of phenyl ring. The compounds of the present invention have wide antibacterial spectrum, superior antibacterial activity and low toxicity, such that the compound of this invention can be used as an antibacterial agent.

  本发明涉及新颖的噁唑烷酮衍生物，其药用盐以及其制备方法。更具体地，本发明涉及在苯环的4位被杂环和杂芳环取代的噁唑烷酮衍生物。本发明的化合物具有广泛的抗菌谱、优越的抗菌活性和低毒性，因此本发明的化合物可用作抗菌剂。
• Novel lincomycin derivatives possessing antimicrobial activity
  申请人：Lewis G. Jason

  公开号：US20050043248A1

  公开（公告）日：2005-02-24

  Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibit antibacterial activity. The compounds of the subject invention may exhibit potent activities against bacteria, including gram positive organisms, and may be useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.

  新型的林可霉素衍生物被披露。这些林可霉素衍生物表现出抗菌活性。本发明的化合物可能对细菌，包括革兰氏阳性生物，表现出强效活性，并且可能是有用的抗微生物药剂。该化合物的合成和使用方法也被披露。
• Novel lincomycin derivatives possessing antibacterial activity
  申请人：Lewis G. Jason

  公开号：US20050215488A1

  公开（公告）日：2005-09-29

  Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibit antibacterial activity. The compounds of the subject invention may exhibit potent activities against bacteria, including Gram positive organisms, and may be useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.

  新型的林可霉素衍生物已被披露。这些林可霉素衍生物表现出抗菌活性。本发明的化合物可能对细菌，包括革兰氏阳性生物，表现出强效活性，并可能是有用的抗微生物药剂。该化合物的合成和使用方法也已被披露。
• Monoacylglycerol Lipase Modulators
  申请人：Janssen Pharmaceutica NV

  公开号：US20200102311A1

  公开（公告）日：2020-04-02

  Bridged compounds of Formula (I) and Formula (II), pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with MGL modulation, such as those associated with pain, psychiatric disorders, neurological disorders (including, but not limited to major depressive disorder, treatment resistant depression, anxious depression, bipolar disorder), cancers and eye conditions. wherein R 2 , R 3 R 4 , R 5 and R 6 are defined herein.

  桥接化合物，其结构式为(I)和(II)，包含它们的药物组合物，制造它们的方法，以及使用它们的方法，包括用于治疗与MGL调节相关的疾病状态、障碍和状况的方法，如与疼痛、精神障碍、神经障碍（包括但不限于重性抑郁障碍、难治性抑郁、焦虑性抑郁、双相情感障碍）、癌症和眼科疾病相关的方法。 其中R2、R3、R4、R5和R6的定义如下。
• Highly Chemoselective Iridium Photoredox and Nickel Catalysis for the Cross-Coupling of Primary Aryl Amines with Aryl Halides
  作者：Martins S. Oderinde、Natalie H. Jones、Antoine Juneau、Mathieu Frenette、Brian Aquila、Sharon Tentarelli、Daniel W. Robbins、Jeffrey W. Johannes

  DOI：10.1002/anie.201604429

  日期：2016.10.10

  visible‐light‐promoted iridium photoredox and nickel dual‐catalyzed cross‐coupling procedure for the formation C−N bonds has been developed. With this method, various aryl amines were chemoselectively cross‐coupled with electronically and sterically diverse aryl iodides and bromides to forge the corresponding C−N bonds, which are of high interest to the pharmaceutical industries. Aryl iodides were found to be a more

  已经开发了可见光促进的铱光氧化还原和镍双催化交叉偶联过程，以形成CN键。通过这种方法，将各种芳基胺与电子和空间上不同的芳基碘化物和溴化物进行化学选择性交联，以形成相应的C-N键，这在制药工业中引起了极大的兴趣。发现芳基碘化物是更有效的亲电子偶联伴侣。偶联反应是在室温下进行的，没有严格排除分子氧，因此使这种新开发的Ir-photoredox / Ni双催化过程非常温和且操作简单。